Evidence map›Paper›PMID 39602366›Full record

ArticleJournal of the American Society of Nephrology : JASN2025

Prevalence and Impact of APOL1 Kidney Risk Variants in West Africa : Insights for Global Kidney Disease Assessment and Treatment.

Elena Martinelli, Rik Westland, Opeyemi A Olabisi, Simone Sanna-Cherchi

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elena MartinelliDivision of Nephrology, Department of Medicine, Columbia University, New York, New York.ORCID 0009-0004-3983-1116
Rik WestlandDepartment of Pediatric Nephrology, Emma Children's Hospital - Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-4960-4078
Opeyemi A OlabisiDepartment of Medicine, Division of Nephrology and Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-0886-7605
Simone Sanna-CherchiDivision of Nephrology, Department of Medicine, Columbia University, New York, New York.ORCID 0000-0002-6185-948

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Integrating large scale genomics and functional studies to accelerate FSGS/NS discoveryRC2DK122397 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HILDEBRANDT, FRIEDHELM, POLLAK, MARTIN R. · 2020 to 2024
$7.4M
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney DiseaseR01MD016401 · NIMHD · DUKE UNIVERSITY · PI OLABISI, OPEYEMI AYODEJI · 2021 to 2025
$3.5M
A Human Stem Cell-Derived Podocyte Model for APOL1 NephropathyDP2DK124891 · NIDDK · DUKE UNIVERSITY · PI OLABISI, OPEYEMI AYODEJI · 2019 to 2019
$2.4M
Dutch kidney foundation 20OC002 and 24OK1076NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1TR001873NIDDK NIH HHS DP2 DK124891NIDDK NIH HHS RC2 DK122397NIH HHS R01MD016401-01 and DP2DK124891-01NIH HHS RC2DK122397NIMHD NIH HHS R01 MD016401U.S. Department of Defense W81XWH-16-1-0451, W81XWH-22-1-0966US Department of Defense W81XWH-16-1-0451, W81XWH-22-1-0966
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39602366
PMCPMC11888956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.